Add BrightSurf on Google Email

Science News Archive October 2003 - Page 8


Page 8 of 10

New hybrid material has potential use in microelectronics

Researchers have developed a new hybrid material with superior insulating properties, which could help address the performance limitations of smaller chip components. The material, called three-ring periodic mesoporous organosilica (PMO), is a porous solid that combines organic and inorganic parts to create a stable molecular assembly.

SourceUniversity of Toronto·JournalScience·DateOct 9, 2003

Purdue team solves structure of West Nile virus

Purdue University biologists have determined the structure of the West Nile virus, a development that could greatly augment our understanding of the virus' life cycle. The research uses cryoelectron microscopy and advanced imaging techniques to understand how the major surface proteins interact with each other.

SourcePurdue University·JournalScience·DateOct 9, 2003

Exercise for elders: It's never too late

Research highlights the importance of exercise for older adults, dispelling stereotypes that age means poor health. Regular physical activity can benefit elderly individuals as much as younger people, enabling them to maintain independence and manage daily functions.

SourceCenter for Advancing Health·JournalAmerican Journal of Preventive Medicine·DateOct 8, 2003

The genetics of blindness

Researchers at McGill University Health Centre identify two key gene mutations in French-Canadian families with retinitis pigmentosa. The study reveals variable and severe symptoms, including hearing loss. The breakthrough promises new screening and diagnostic tests for affected families.

SourceMcGill University·JournalAmerican Journal of Ophthalmology·DateOct 8, 2003

Study shows that forgiveness can be taught

A study on forgiveness methodology found a 70% decrease in feelings of hurt, 27% reduction in physical symptoms, and 34% increase in forgiveness for those who participated in the six-week training program. The research, led by Dr. Frederic Luskin, validates the effectiveness of this specific forgiveness approach.

HIV vaccine in worldwide trial

Vanderbilt University is one of nine US sites participating in a phase I trial of the Merck HIV vaccine, designed to test its safety and ability to stimulate immune responses in healthy volunteers. The study aims to generate cellular immune responses that could prevent the virus from spreading in the body.